InMed Pharmaceuticals Inc. /
Mentari Therapeutics, Inc.
InMed Pharmaceuticals Inc. signed an agreement for Mentari Therapeutics, Inc.




Source for the buyer and target: InMed Pharmaceuticals Inc.
For the buyer and target.
buyer
“Vancouver, British Columbia – September 9, 2026 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reported financial results for its fiscal year ended June 30, 2026.”
target
“In May 2026, InMed entered into a definitive merger agreement with Mentari Therapeutics, Inc. (“Mentari”), a privately held biotechnology company developing next-generation therapies for migraine prevention.”
Published 9 Sep 2026
Open the sourceWhat happened
The deal for Mentari Therapeutics, Inc. is signed, with InMed Pharmaceuticals Inc. as the buyer. [01]
The filing from InMed Pharmaceuticals Inc. is dated Sept. 9, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
InMed Pharmaceuticals Inc. signed an agreement for Mentari Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Agreement signed · InMed Pharmaceuticals Inc. / Mentari Therapeutics, Inc. deal (Agreement signed, published 9 Sep 2026).
Announced 9 Sep 2026- Announced
- Published by InMed Pharmaceuticals Inc.
Deal Web as a list
- InMed Pharmaceuticals Inc. (Buyer) buyer this deal. InMed Pharmaceuticals Inc.: 1 deal on Carrywatch.
By email · Weekly